{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T13:21:54Z","timestamp":1769952114672,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Bergh in het Zadel Foundation for the fight against cancer","award":["research into precancerous breast cancer"],"award-info":[{"award-number":["research into precancerous breast cancer"]}]},{"name":"Bergh in het Zadel Foundation for the fight against cancer","award":["Lobular"],"award-info":[{"award-number":["Lobular"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1245\/s10434-024-16686-8","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T17:51:50Z","timestamp":1735581110000},"page":"2545-2553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Surgery for Classic, Pleomorphic and Non-classic Lobular Carcinoma In Situ: Surgery Rate, Risk of Upstaging and Short-Term Follow-Up"],"prefix":"10.1245","volume":"32","author":[{"given":"Claudia J. C.","family":"Meurs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Kerkhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian B. E.","family":"Menke-Pluijmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter J.","family":"Westenend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"issue":"3","key":"16686_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2214\/AJR.07.2768","volume":"190","author":"RF Brem","year":"2008","unstructured":"Brem RF, Lechner MC, Jackman RJ, et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. Am J Roentgenol. 2008;190(3):637\u201341. https:\/\/doi.org\/10.2214\/AJR.07.2768.","journal-title":"Am J Roentgenol"},{"key":"16686_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.breast.2021.07.020","volume":"59","author":"MC van Maaren","year":"2021","unstructured":"van Maaren MC, \u00c1vila AO, van Manen JG, et al. Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: a population-based analysis. Breast. 2021;59:376\u201382. https:\/\/doi.org\/10.1016\/j.breast.2021.07.020.","journal-title":"Breast"},{"issue":"7","key":"16686_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","volume":"37","author":"DJ Dabbs","year":"2013","unstructured":"Dabbs DJ, Schnitt SJ, Geyer FC, et al. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol. 2013;37(7):e1-11.","journal-title":"Am J Surg Pathol."},{"issue":"4","key":"16686_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3322\/canjclin.32.4.234","volume":"17","author":"FW Foote","year":"1941","unstructured":"Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol. 1941;17(4):491\u20136. https:\/\/doi.org\/10.3322\/canjclin.32.4.234.","journal-title":"Am J Pathol"},{"key":"16686_CR5","unstructured":"WHO Classification of Tumors Editorial Board. Breast Tumours. WHO Classification of Tumours. 5th ed. Lyon: IARC; 2019."},{"issue":"6","key":"16686_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/tbj.13857","volume":"26","author":"C Calle","year":"2020","unstructured":"Calle C, Kuba MG, Brogi E. Non-invasive lobular neoplasia of the breast: morphologic features, clinical presentation, and management dilemmas. Breast J. 2020;26(6):1148\u201355. https:\/\/doi.org\/10.1111\/tbj.13857.","journal-title":"Breast J."},{"key":"16686_CR7","unstructured":"NABON. Dutch breast cancer guideline. Published 2012. https:\/\/www.nabon.nl\/wp-content\/uploads\/2022\/10\/Dutch-Breast-Cancer-Guideline-2012.pdf. Accessed 11 June 2024."},{"key":"16686_CR8","unstructured":"Federation of Medical Specialists. Federatie Medisch Specialisten, KvK: 40483480. https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/startpagina_-_borstkanker.html."},{"key":"16686_CR9","doi-asserted-by":"publisher","unstructured":"Rageth CJ, O\u2019Flynn EAM, Pinker K, et al. Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat. 2019;174(2):279\u201396. https:\/\/doi.org\/10.1007\/s10549-018-05071-1","DOI":"10.1007\/s10549-018-05071-1"},{"issue":"8","key":"16686_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.crad.2018.04.004","volume":"73","author":"SE Pinder","year":"2018","unstructured":"Pinder SE, Shaaban A, Deb R, et al. NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). Clin Radiol. 2018;73(8):682\u201392. https:\/\/doi.org\/10.1016\/j.crad.2018.04.004.","journal-title":"Clin Radiol"},{"issue":"8","key":"16686_CR11","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194\u2013220. https:\/\/doi.org\/10.1093\/annonc\/mdz173.","journal-title":"Ann Oncol"},{"issue":"3","key":"16686_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12609-021-00415-1","volume":"13","author":"AM Shaaban","year":"2021","unstructured":"Shaaban AM. Why is LCIS important\u2014pathological review. Curr Breast Cancer Rep. 2021;13(3):132\u201340. https:\/\/doi.org\/10.1007\/s12609-021-00415-1.","journal-title":"Curr Breast Cancer Rep"},{"issue":"12","key":"16686_CR13","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1111\/tbj.14085","volume":"26","author":"K Singh","year":"2020","unstructured":"Singh K, Sung CJ, Quddus MR. Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy. Breast J. 2020;26(12):2350\u20136. https:\/\/doi.org\/10.1111\/tbj.14085.","journal-title":"Breast J"},{"key":"16686_CR14","doi-asserted-by":"crossref","unstructured":"Casparie M, Tiebosch a TMG, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cellular Oncol. 2007;29(1):19-24.","DOI":"10.1155\/2007\/971816"},{"issue":"7","key":"16686_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/his.12353","volume":"64","author":"T Khoury","year":"2014","unstructured":"Khoury T, Karabakhtsian RG, Mattson D, et al. Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases. Histopathology. 2014;64(7):981\u201393. https:\/\/doi.org\/10.1111\/his.12353.","journal-title":"Histopathology."},{"issue":"11","key":"16686_CR16","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","volume":"33","author":"YY Chen","year":"2009","unstructured":"Chen YY, Hwang ESS, Roy R, et al. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol. 2009;33(11):1683\u201394. https:\/\/doi.org\/10.1097\/PAS.0b013e3181b18a89.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"16686_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10549-017-4334-1","volume":"165","author":"M De Brot","year":"2017","unstructured":"De Brot M, Koslow Mautner S, Muhsen S, et al. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review. Breast Cancer Res Treat. 2017;165(2):411\u201320. https:\/\/doi.org\/10.1007\/s10549-017-4334-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"16686_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10549-007-9557-0","volume":"107","author":"S Aulmann","year":"2008","unstructured":"Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat. 2008;107(3):331\u20135. https:\/\/doi.org\/10.1007\/s10549-007-9557-0.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"16686_CR19","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jacr.2020.07.036","volume":"17","author":"MN Shehata","year":"2020","unstructured":"Shehata MN, Rahbar H, Flanagan MR, et al. Risk for upgrade to malignancy after breast core needle biopsy diagnosis of lobular neoplasia: a systematic review and meta-analysis. J Am Coll Radiol. 2020;17(10):1207\u201319. https:\/\/doi.org\/10.1016\/j.jacr.2020.07.036.","journal-title":"J Am Coll Radiol"},{"issue":"5","key":"16686_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1067\/j.cpradiol.2018.06.004","volume":"48","author":"E Falomo","year":"2019","unstructured":"Falomo E, Adejumo C, Carson KA, Harvey S, Mullen L, Myers K. Variability in the management recommendations given for high-risk breast lesions detected on image-guided core needle biopsy at U.S. Academic Institutions. Curr Probl Diagn Radiol. 2019;48(5):462\u20136. https:\/\/doi.org\/10.1067\/j.cpradiol.2018.06.004.","journal-title":"Curr Probl Diagn Radiol"},{"issue":"2","key":"16686_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00428-019-02685-8","volume":"476","author":"IS Genco","year":"2020","unstructured":"Genco IS, Tugertimur B, Chang Q, Cassell L, Hajiyeva S. Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study. Virchows Archiv. 2020;476(2):209\u201317. https:\/\/doi.org\/10.1007\/s00428-019-02685-8.","journal-title":"Virchows Archiv"},{"issue":"4","key":"16686_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2214\/AJR.11.8447","volume":"199","author":"B Niell","year":"2012","unstructured":"Niell B, Specht M, Gerade B, Rafferty E. Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? Am J Roentgenol. 2012;199(4):929\u201335. https:\/\/doi.org\/10.2214\/AJR.11.8447.","journal-title":"Am. J. Roentgenol"},{"key":"16686_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.breast.2017.12.011","volume":"38","author":"YA Masannat","year":"2018","unstructured":"Masannat YA, Husain E, Roylance R, et al. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ. Breast. 2018;38:120\u20134. https:\/\/doi.org\/10.1016\/j.breast.2017.12.011.","journal-title":"Breast"},{"issue":"12","key":"16686_CR24","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.ejso.2019.07.011","volume":"45","author":"MP Foschini","year":"2019","unstructured":"Foschini MP, Miglio R, Fiore R, et al. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature. Eur J Surg Oncol. 2019;45(12):2279\u201386. https:\/\/doi.org\/10.1016\/j.ejso.2019.07.011.","journal-title":"Eur J Surg Oncol"},{"key":"16686_CR25","doi-asserted-by":"publisher","DOI":"10.5061\/dryad.6354b","author":"VP Andrade","year":"2012","unstructured":"Andrade VP, Ostrovnaya I, Seshan VE, et al. Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions. DRYAD. 2012. https:\/\/doi.org\/10.5061\/dryad.6354b.","journal-title":"DRYAD"},{"issue":"2","key":"16686_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.molonc.2015.11.001","volume":"10","author":"RA Sakr","year":"2016","unstructured":"Sakr RA, Schizas M, Carniello JVS, et al. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships. Mol Oncol. 2016;10(2):360\u201370. https:\/\/doi.org\/10.1016\/j.molonc.2015.11.001.","journal-title":"Mol Oncol."},{"issue":"1","key":"16686_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-016-0789-y","volume":"19","author":"V Shah","year":"2017","unstructured":"Shah V, Nowinski S, Levi D, et al. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression. Breast Cancer Res. 2017;19(1):1. https:\/\/doi.org\/10.1186\/s13058-016-0789-y.","journal-title":"Breast Cancer Res"},{"issue":"12","key":"16686_CR28","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1002\/cncr.20273","volume":"100","author":"SE Hwang","year":"2004","unstructured":"Hwang SE, Nyante SJ, Yi Chen Y, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer. 2004;100(12):2562\u201372. https:\/\/doi.org\/10.1002\/cncr.20273.","journal-title":"Cancer"},{"issue":"1","key":"16686_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-016-0727-z","volume":"18","author":"CB Begg","year":"2016","unstructured":"Begg CB, Ostrovnaya I, Carniello JVS, et al. Clonal relationships between lobular carcinoma in situ and other breast malignancies. Breast Cancer Res. 2016;18(1):1. https:\/\/doi.org\/10.1186\/s13058-016-0727-z.","journal-title":"Breast Cancer Res"},{"issue":"12","key":"16686_CR30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1097\/00000478-200012000-00009","volume":"24","author":"LP Middleton","year":"2000","unstructured":"Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol. 2000;24(12):1650\u20136.","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"16686_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1806","volume":"207","author":"JS Reis-Filho","year":"2005","unstructured":"Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol. 2005;207(1):1\u201313. https:\/\/doi.org\/10.1002\/path.1806.","journal-title":"J Pathol"},{"issue":"7","key":"16686_CR32","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1403::AID-CNCR6>3.0.CO;2-L","volume":"78","author":"ER Fisher","year":"1996","unstructured":"Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: five-year observations concerning lobular carcinoma in situ. Cancer. 1996;78(7):1403\u201316. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19961001)78:7%3c1403::AID-CNCR6%3e3.0.CO;2-L.","journal-title":"Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16686-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16686-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16686-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:28:52Z","timestamp":1741195732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16686-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["16686"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16686-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Claudia J.C. Meurs, Crystal Kerkhoven, Sabine Siesling, Marian B.E. Menke-Pluijmers, and Pieter J. Westenend declare they have no conflicts of interest that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This was an observational study, a retrospective cohort study for which no ethical approval was required. Datasets were used and the use of these datasets was approved by the Scientific Committee of Palga (14.025 LZV1073 and LZV 2019-57).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}